Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis

Journal of Cell Biology

Volumn 144, Issue 5, 1999, Pages 903-914

  Griffiths, Gareth J ^a   Dubrez, Laurence ^a   Morgan, Clive P ^a   Jones, Neil A ^a   Whitehouse, Jenna ^a   Corfe, Bernard M ^a   Dive, Caroline ^a   Hickman, John A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Dexamethasone; Etoposide; Flow cytometry; Protein protein interactions; Staurosporine

Indexed keywords

PROTEIN BAK; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DAMAGE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN STRUCTURE;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASPASES; CELL CYCLE; DEXAMETHASONE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME ACTIVATION; EPITOPES; ETOPOSIDE; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; PROTEIN CONFORMATION; STAUROSPORINE; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

EID: 0033535347     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.144.5.903     Document Type: Article

References (45)

1. Amarante-Mendes, G.P., D.M. Finucane, S.J. Martin, T.G. Cotter, G.S. Salvesen, and D.G. Green. 1998. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. 5:298-306.
2. Boersma, A.W.M., K. Nooter, H. Burger, C.J. Kortland, and G. Stoter. 1997. Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry. Cytometry. 27:275-282.
3. Boise, L.H., M. Gonzalez-Garcia, C.E. Postems, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson, 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597-608.
4. Brunet, C.L., R.H. Gunby, R.S.P. Benson, J.A. Hickman, A.J.M. Watson, and G. Brady. 1998. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ. 5:107-115.
5. Canman, C.E., T.M. Gilmer, S.B. Coutts, and M.B. Kastan. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:600-611.
6. Chen, Q., J. Turner, A.J.M. Watson, and C. Dive. 1997. v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL. Oncogene. 15:2249-2252.
7. L. Nature. 379:554-556.
8. Chittenden, T., C. Flemington, A.B. Houghton, R.G. Ebb, G.J. Gallo, B. Elangovan, G. Chinnadurai, and R.J. Lutz. 1995. A conserved domain in Bak distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO (Eur. Mol. Biol. Organ.) J. 14:5589-5596.
9. Chresta, C.M., J.R.W. Masters, and J.A. Hickman. 1996. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res. 56:1834-1841.
10. Elangovan, B., and G. Chinnadurai. 1997. Functional dissection of the proapoptotic protein Bik. J. Biol. Chem. 272:24494-24498.
11. Farrow, S.N., J.H.M. White, I. Martinou, T. Raven, K.-T. Pun, C.J. Grinham, J.-C. Martinou, and R. Brown. 1995. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:731-733.
12. Gajewski, T.F., and C.B. Thompson. 1996. Apoptosis meets signal transduction: elimination of a BAD influence. Cell. 87:589-592.
13. Guan, R.J., S.F. Moss, N. Arber, S. Krajewski, J.C. Reed, and P.R. Holt. 1996. 30 KDa phosphorylated form of Bcl-2 protein in human colon. Oncogene. 12:2605-2609.
14. Gross, A., J. Jockel, M.C. Wei, and S.J. Korsmeyer. 1998. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO (Eur. Mol. Biol. Organ.) J. 17:3878-3885.
15. Haldar, S., N. Jena, and C.M. Croce. 1995. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA. 92:4507-4511.
16. Hanada, M., C. Amie-Sempe, T. Sato, and J.C. Reed. 1995. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J. Biol. Chem. 270:11962-11969.
17. Hsu, Y.-T., and R.J. Youle. 1997. Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 272:13829-13834.
18. Ito, T., X. Deng, B. Carr, and W.S. May. 1997. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272:11671-11673.
19. Kelekar, A., and C.B. Thompson. 1998. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8:324-330.
20. Knowles, R.W. 1987. In Histocompatibility Testing. B. Dupont, editor. Springer Verlag, New York. 1-45.
21. Knudson, C.M., and S.J. Korsmeyer. 1997. Bcl-2 and Bax function independently to regulate cell death. Nature Genetics. 16:358-363.
22. Korsmeyer, S.J., J.R. Shutter, D.J. Veis, D.E. Merry, and Z.N. Oltvai. 1993. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Sem. Cancer Biol. 4:327-332.
23. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 6:614-620.
24. Ling, Y.-H., C. Tornos, and R. Perez-Soler. 1998. Phosphorylation of Bcl-2 is a marker of M-phase events and not a determinant of apoptosis. J. Biol. Chem. 273:18984-18991.
25. May, W.S., P.G. Tyler, T. Ito, D.K. Armstrong, K.A. Qatsha, and N.E. Davidson. 1994. The proto-oncogene Bcl-2 and its role in regulating apoptosis. J. Biol. Chem. 269:26865-26870.
26. McCarthy, N.J., M.K.B. Whyte, C.S. Gilbert, and G.I. Evan. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes. DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:215-227.
27. Miyashita, T., S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffman, and J.C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799-1805.
28. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609-619.
29. Reed, J.C. 1997. Double identity for proteins of the Bcl-2 family. Nature. 387:773-776.
30. Salvesen, G.S., and V.M. Dixit. 1997. Caspases: intracellular signaling by proteolysis. Cell. 91:443-446.
31. Sanchez-Garcia, R., and G. Grutz. 1995. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc. Natl. Acad. Sci. USA. 92: 5287-5291.
32. Sato, T., M. Hanada, S. Bodrug, S. Irie, N. Iwama, L.H. Boise, C.B. Thompson, E. Golemis, L. Fong, H.-G. Wang, and J.C. Reed. 1994. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238-9242.
33. Sedlak, T.W., Z.N. Oltvai, E. Yang, K. Wang, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer. 1995. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA. 92:7834-7838.
34. L-Bak peptide complex: recognition between regulators of apoptosis. Science. 275:983-986.
35. L and Bcl-2. Oncogene. 15:1871-1875.
36. Vander-Heiden, M.G., N.S. Chandel, E.K. Williamson, P.T. Schumacker, and C.B. Thompson. 1997. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:627-637.
37. Walker, A., S.T. Taylor, J.A. Hickman, and C. Dive. 1997. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Cancer Res. 57: 1939-1945.
38. Wang, K., X.-M. Yin, D.T. Chao, C.L. Milliman, and S.J. Korsmeyer. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:2859-2869.
39. Wolter, K.G., Y.-T. Hsu, C.L. Smith, A. Nechushtan, X.-G. Xi, and R.J. Youle. 1997. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1281-1292.
40. Wood, A.C., P. Elvin, and J.A. Hickman. 1995. Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br. J. Cancer. 71:937-941.
41. Xiang, J., D.T. Chao, and S.J. Korsmeyer. 1996. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:14559-14563.
42. Yang, E., and S.J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88:386-401.
43. Yang, X., R. Khosravi-Far, H.Y. Chang, and D. Baltimore. 1997. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 89: 1067-1076.
44. Zamzami, N., C. Brenner, I. Marzo, S.A. Susin, and G. Kroemer. 1998. Subcellular and submitochondrial mode of action of Bcl-2-like proteins. Oncogene. 16:2265-2282.
45. Zha, H., C. Aime-Sempe, T. Sato, and J.C. Reed. 1996. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J. Biol. Chem. 271:7440-7444.